Beam Therapeutics

Gene editing CRISPR gene therapy
Biotech

Beam gene therapy passes early safety test in AATD

The one-time gene therapy is designed to use CRISPR to precisely cut and fix the single errant letter of DNA that causes the majority of AATD cases.
Darren Incorvaia Mar 10, 2025 12:22pm
DNA strand gene editing

Beam hits hemoglobin goal in first base editing clinical data

Nov 5, 2024 9:00am
Graphic of three faceless profiles aimed diagonally to the right with two check marks in between them Orange background

Third Rock adds 3 new venture partners, including Karuna’s Paul

Jan 25, 2024 10:35am
Beam alien spacecraft UFO halloween

Beam offloads Verve rights to Lilly for up to $600M

Oct 31, 2023 6:00am
layoff workforce cuts reduction stock

Beam lays off 20% of staff and culls CAR-T work to save cash

Oct 19, 2023 11:00am
A silver slightly shiny strands of DNA appear against a background of clocks

Beam aims to dose first patient in sickle cell trial this year

Aug 8, 2023 4:10pm